InvestorsHub Logo
icon url

Globewriter

05/23/20 6:59 AM

#333915 RE: peregr #333914

A message relayed on the interim look by the IDMC ; “The IDMC will be unmasked along with the rest of the biomarker analysis from Epiontis & Precision For Medicine” “The Board of Regents discussion meetings will also be unmasked for their lobbying to get exosomes back to UTSWM” “This was the most daring attempt for some to go through by using Ronin Capital for leverage and only to take him down after the plan starts to fall apart”
“Jedd Wolchok strikes gold on new PS Targeting drugs as patents pending” “Contract with Oncologie Inc null and void (just in time as new biomarker analysis propels Exosome Diagnostics and all IP assets will drive exosome technology to new heights) and Heat Biologics Jeff Hutchins has some PS Targeting relevant data on those cold tumors to hot in time for ASCO. “

“The story has not been written just yet as the IP assets are back”

I guess that means the sell out at $10 or $15 becomes null and void and wouldn’t this unmasking of Ronin Capital and others, shall bring one hell of a message on this Memorial Day weekend that justice will prevail.

Jason Stafford was at “protein simple” but that was bought out by “Biotechne..”

Biotechne and others ...all into exosomes as Biotechne buys Exosome Diagnostics

Orbimed and Perceptive - Very Clever